why choose us

First received: March 28, 2023

Clinical Trial: Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alpha 1-Antitrypsin Deficiency

Study Type: INTERVENTIONAL


Official Title: Phase 2, Double-Blind, Randomized, Active-Control, Parallel Group Study to Assess the Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of INBRX-101 Compared to Plasma-Derived Alpha1-Prot

Brief Summary: Phase 2 study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD emphysema

Read more